Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seki

Showing results (251-260 of 551) with videos related to

Pageof 56
Sort By:
Acta Dermato-Venereologica|February 1, 1993
Epidermodysplasia verruciformis accompanied by familial large granular lymphocytosis and a decrease in T lymphocytesH Aoyama, S Seki, T Abo, et al.
Masui. the Japanese Journal of Anesthesiology|October 1, 1994
[Evaluation of midazolam premedication for preoperative anxiolysis]N Tago, N Kanaya, M Nakayama, et al.
Human Cell|April 3, 2002
Telomerase activation and MAPK pathways in regenerating hepatocytesT Inui, N Shinomiya, M Fukasawa, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1983
Facilitation of intrathoracic operations by means of high-frequency ventilationS Seki, Y Fukushima, K Goto, et al.
British Journal of Cancer|July 1, 1990
The effect of L-dopa on the potentiation of radiation damage to human melanoma cellsI Yamada, S Seki, S Ito, et al.
Japanese Journal of Clinical Oncology|December 1, 1986
Karyotype aberrations and surface marker analyses of the tumor cells of Hodgkin's disease: a case report and review of literatureM Nagai, T Abe, S Seki, et al.
The Journal of Investigative Dermatology|May 1, 1987
The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitroI Yamada, S Seki, O Matsubara, et al.
British Journal of Cancer|December 1, 1988
The killing effects of 4-S-cysteinylcatechol and analogues on human melanoma cellsI Yamada, S Seki, S Ito, et al.
Gastroenterologia Japonica|June 1, 1988
Protective effects of a leukotriene inhibitor in an experimental massive hepatic cell necrosis modelY Mizoguchi, Y Sakagami, S Seki, et al.
Rinsho Hoshasen. Clinical Radiography|October 1, 1985
[The surface markers of non-Hodgkin's disease cells; classification of T and B cell lymphoma and their prognosis]M Shimoyama, K Minato, S Seki, et al.
Pageof 56

Showing results (251-260 of 551) with videos related to

Sort By:
Pageof 56
Acta Dermato-Venereologica|February 1, 1993
Epidermodysplasia verruciformis accompanied by familial large granular lymphocytosis and a decrease in T lymphocytesH Aoyama, S Seki, T Abo, et al.
Masui. the Japanese Journal of Anesthesiology|October 1, 1994
[Evaluation of midazolam premedication for preoperative anxiolysis]N Tago, N Kanaya, M Nakayama, et al.
Human Cell|April 3, 2002
Telomerase activation and MAPK pathways in regenerating hepatocytesT Inui, N Shinomiya, M Fukasawa, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 1, 1983
Facilitation of intrathoracic operations by means of high-frequency ventilationS Seki, Y Fukushima, K Goto, et al.
British Journal of Cancer|July 1, 1990
The effect of L-dopa on the potentiation of radiation damage to human melanoma cellsI Yamada, S Seki, S Ito, et al.
Japanese Journal of Clinical Oncology|December 1, 1986
Karyotype aberrations and surface marker analyses of the tumor cells of Hodgkin's disease: a case report and review of literatureM Nagai, T Abe, S Seki, et al.
The Journal of Investigative Dermatology|May 1, 1987
The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitroI Yamada, S Seki, O Matsubara, et al.
British Journal of Cancer|December 1, 1988
The killing effects of 4-S-cysteinylcatechol and analogues on human melanoma cellsI Yamada, S Seki, S Ito, et al.
Gastroenterologia Japonica|June 1, 1988
Protective effects of a leukotriene inhibitor in an experimental massive hepatic cell necrosis modelY Mizoguchi, Y Sakagami, S Seki, et al.
Rinsho Hoshasen. Clinical Radiography|October 1, 1985
[The surface markers of non-Hodgkin's disease cells; classification of T and B cell lymphoma and their prognosis]M Shimoyama, K Minato, S Seki, et al.
Pageof 56